NLS Pharmaceutics AG
NLSP
查看详细走势图
0.762USD
0.000
收盘 12/24, 13:00（美东）报价延迟15分钟
3.16M总市值
--市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
0.00%
5天
0.00%
1月
0.00%
6月
-66.43%
今年开始到现在
-63.89%
1年
-59.76%
查看详细走势图
TradingKey NLS Pharmaceutics AG股票评分
单位: USD 更新时间: 2025-10-27操作建议
当前估值低估，机构持股占比非常高，近一月多位分析师给出公司评级为。最高目标价max_target_price。目前股价在压力位和支撑位之间，可以做区间波段操作。
NLS Pharmaceutics AG评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
0
位分析师
--
评级
0.000
目标均价
0.00%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
NLS Pharmaceutics AG亮点
亮点风险
NewcelX AG, formerly NLS Pharmaceutics AG, is a Switzerland-based company primarily engaged in the biotechnology industry. The Company focuses on the discovery and development of therapies for rare and complex central nervous system (CNS) disorders, including sleep and neurodevelopmental conditions. The Company offers products like Quilience, which is a clinical-stage pharmaceutical compound. It aims to support the treatment of narcolepsy by modulating monoamine neurotransmission and orexin receptor activity. The Company also develops product like Nolazol, a treatment candidate for Attention Deficit Hyperactivity Disorder (ADHD). The Company is a publicly traded company, listing on the NASDAQ.
NLS Pharmaceutics AG新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
NLS Pharmaceutics AG简介
NewcelX AG, formerly NLS Pharmaceutics AG, is a Switzerland-based company primarily engaged in the biotechnology industry. The Company focuses on the discovery and development of therapies for rare and complex central nervous system (CNS) disorders, including sleep and neurodevelopmental conditions. The Company offers products like Quilience, which is a clinical-stage pharmaceutical compound. It aims to support the treatment of narcolepsy by modulating monoamine neurotransmission and orexin receptor activity. The Company also develops product like Nolazol, a treatment candidate for Attention Deficit Hyperactivity Disorder (ADHD). The Company is a publicly traded company, listing on the NASDAQ.
公司代码NLSP
公司NLS Pharmaceutics AG
CEOZwyer (Alexander)
网址https://nlspharma.com/
常见问题
NLS Pharmaceutics AG(NLSP)的当前股价是多少？
NLS Pharmaceutics AG(NLSP)的当前股价是 0.762。
NLS Pharmaceutics AG的股票代码是什么？
NLS Pharmaceutics AG的股票代码是NLSP。
NLS Pharmaceutics AG股票的52周最高点是多少？
NLS Pharmaceutics AG股票的52周最高点是4.740。
NLS Pharmaceutics AG股票的52周最低点是多少？
NLS Pharmaceutics AG股票的52周最低点是0.740。
NLS Pharmaceutics AG的市值是多少？
NLS Pharmaceutics AG的市值是3.16M。
NLS Pharmaceutics AG的净利润是多少？
NLS Pharmaceutics AG的净利润为-4.06M。
现在NLS Pharmaceutics AG(NLSP)的股票是买入、持有还是卖出？
根据分析师评级，NLS Pharmaceutics AG(NLSP)的总体评级为--，目标价格为--。
NLS Pharmaceutics AG(NLSP)股票的每股收益（EPS TTM）是多少
NLS Pharmaceutics AG(NLSP)股票的每股收益（EPS TTM）是-2.629。
相关品种
